China allows sale of Pfizer oral drug as demand surges in wake of rising COVID cases
The agreement is valid between 14th December and 30th November, 2023, China Meheco said in a filing to the Shanghai stock exchange
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
COVID-19 drug
Merck to take legal action against unauthorised distributors of its COVID treatment in China
Merck added that Sinopharm is the only legally authorised distributor of Merck's COVID-19 anti-viral molnupiravir in China
China Meheco to distribute Pfizer’s COVID treatment in China
Pfizer signed a deal in August for Chinese drugmaker Zhejiang Huahai to produce Paxlovid in mainland China solely for patients…
Indian drug 2DG can reduce heart damage by coronavirus, find US researchers
Their findings, based on research with fruit flies and mouse heart cells, were published in 'Communications Biology,' a 'Nature'…
Japan’s Fujifilm stops work on Avigan as COVID drug
In March, Fujifilm had cut short enrolment in a phase-III trial, saying the emergence of the Omicron variant made it tough to…
IDRS Labs seeks emergency nod for plant-based drug against long COVID
A tripartite Memorandum of Agreement was signed among BARC, ACTREC-TMC and IDRS to develop Chlorophyllin against COVID-19 disease…
Dolo 650 maker rejects allegations of Rs 1,000 crore worth freebies to doctors
The annual sales of Dolo 650 have been Rs 360 crore, about eight per cent of the company sales
FDA declines to authorise common antidepressant as COVID treatment
The generic drug belongs to an old, widely-used class of antidepressants called Selective Serotonin Reuptake Inhibitors (SSRIs)
WHO recommends Pfizer’s Paxlovid for wide geographical distribution
Pfizer’s oral antiviral drug (a combination of Nirmatrelvir and Ritonavir tablets) is strongly recommended for patients with…